Main site ↗

Docs / GAISSF™ / Sector guidance

GAISSF™ Pharmaceutical Sector Executive Primer

ID SEC-049A Framework GAISSF™ Type Sector guidance

Download PDF Document record

What it coversExecutive orientation to pharmaceutical implementation and assurance evidence.
Scope and limitsNo universal global regulatory classification or validation method for pharmaceutical AI is assumed. Model accuracy alone is not treated as evidence of clinical, safety, quality or regulatory fitness.

Revision history

Date (as stated)EventWhat changed
5 Oct 2026Document revisionDraft for Publication issued; external review openSource: GAISSF-SEC-049A_Pharmaceutical_Executive_Primer_v1.0.pdf

Earlier editions

Superseded copies, kept for reference and citation checks. Use the current edition above for any new work. Dates and statuses are as printed in each copy. An edition marked “held” is not republished; its checksum lets you confirm whether a copy you hold is that edition.

Earlier editions of this document
Edition (as printed)Status (as printed)File
Version 1.1 (date not printed)Held, not republished Executive primer (PDF). Not available from this site.SHA-256 c5d8ccde39bde6b7a193855d08315347480542ed00bc85d15c555eae7d4e59f7

More from GAISSF™

SEC-047GAISSF™ Telecommunications Sector Implementation Guide
NOR-001GAISSF™ Framework Standard
NOR-002GAISSF™ Executive Summary
NOR-003GAISSF™ Quick Start Guide
Cite this document
ODA3 Institute. GAISSF™ Pharmaceutical Sector Executive Primer (SEC-049A), v1.0. 5 Oct 2026. docs.oda3.org/documents/sec-049a/

Report a correction or ask about this publication